(345731, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345732, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345733, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345734, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345735, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345736, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345737, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345738, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345739, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345740, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345741, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345742, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345743, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345744, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345745, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345746, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345747, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345748, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345749, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345750, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345751, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345752, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345753, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345754, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345755, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345756, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345757, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345758, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345759, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345760, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345761, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345762, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345763, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345764, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345765, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345766, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345767, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345768, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345769, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345770, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345771, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345772, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345773, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345774, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345775, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345776, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345777, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345778, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345779, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345780, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345781, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345782, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345783, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345784, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345785, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345786, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345787, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345788, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345789, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345790, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345791, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345792, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345793, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345794, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345795, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345796, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345797, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345798, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345799, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345800, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345801, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345802, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345803, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345804, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345805, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345806, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345807, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345808, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345809, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345810, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345811, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345812, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345813, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345814, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345815, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345816, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345817, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345818, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345819, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345820, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345821, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345822, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345823, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345824, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345825, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345826, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345827, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345828, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345829, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345830, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345831, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345832, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345833, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345834, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345835, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345836, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345837, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345838, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345839, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345840, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345841, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345842, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345843, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345844, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345845, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345846, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345847, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345848, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345849, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345850, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345851, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345852, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345853, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345854, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345855, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345856, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345857, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345858, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345859, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345860, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345861, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345862, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345863, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345864, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345865, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345866, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345867, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345868, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345869, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345870, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345871, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345872, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345873, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345874, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345875, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345876, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345877, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345878, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345879, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345880, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345881, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345882, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345883, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345884, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345885, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345886, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345887, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345888, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345889, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345890, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345891, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345892, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345893, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345894, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345895, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345896, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345897, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345898, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345899, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345900, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345901, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345902, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345903, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345904, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345905, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345906, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345907, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345908, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345909, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345910, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345911, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345912, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345913, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345914, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345915, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345916, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345917, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345918, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345919, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345920, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345921, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345922, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345923, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345924, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345925, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345926, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345927, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345928, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345929, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345930, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345931, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345932, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345933, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345934, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345935, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345936, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345937, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345938, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345939, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345940, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345941, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345942, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345943, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345944, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345945, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345946, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345947, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345948, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345949, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345950, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345951, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345952, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345953, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345954, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345955, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345956, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345957, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345958, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345959, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345960, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345961, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345962, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345963, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345964, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345965, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345966, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345967, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345968, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345969, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345970, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345971, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345972, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345973, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345974, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345975, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345976, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345977, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345978, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345979, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345980, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345981, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345982, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345983, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345984, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345985, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345986, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345987, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345988, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345989, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345990, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345991, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345992, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345993, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345994, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345995, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345996, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345997, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(345998, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(345999, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346000, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346001, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346002, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346003, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346004, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346005, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346006, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346007, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346008, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346009, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346010, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346011, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346012, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346013, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346014, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346015, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346016, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346017, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346018, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346019, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346020, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346021, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346022, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346023, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346024, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346025, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346026, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346027, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346028, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346029, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346030, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346031, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346032, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346033, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346034, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346035, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346036, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346037, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346038, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346039, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346040, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346041, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346042, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346043, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346044, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346045, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346046, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346047, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346048, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346049, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346050, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346051, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346052, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346053, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346054, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346055, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346056, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346057, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346058, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346059, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346060, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346061, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346062, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346063, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346064, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346065, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346066, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346067, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346068, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346069, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346070, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346071, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346072, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346073, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346074, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346075, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346076, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346077, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346078, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346079, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346080, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346081, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346082, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346083, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346084, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346085, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346086, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346087, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346088, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346089, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346090, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346091, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346092, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346093, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346094, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346095, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346096, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346097, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346098, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346099, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346100, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346101, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346102, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346103, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346104, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346105, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346106, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346107, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346108, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346109, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346110, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346111, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346112, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346113, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346114, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346115, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346116, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346117, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346118, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346119, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346120, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346121, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346122, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346123, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346124, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346125, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346126, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346127, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346128, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346129, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346130, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346131, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346132, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346133, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346134, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346135, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346136, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346137, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346138, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346139, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346140, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346141, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346142, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346143, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346144, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346145, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346146, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346147, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346148, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346149, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346150, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346151, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346152, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346153, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346154, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346155, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346156, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346157, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346158, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346159, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346160, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346161, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346162, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346163, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346164, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346165, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346166, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346167, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346168, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346169, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346170, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346171, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346172, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346173, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346174, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346175, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346176, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346177, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346178, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346179, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346180, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346181, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346182, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346183, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346184, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346185, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346186, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346187, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346188, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346189, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346190, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346191, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346192, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346193, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346194, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346195, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346196, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346197, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346198, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346199, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346200, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346201, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346202, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346203, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346204, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346205, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346206, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346207, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346208, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346209, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346210, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346211, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346212, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346213, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346214, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346215, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346216, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346217, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346218, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346219, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346220, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346221, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346222, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346223, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346224, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346225, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346226, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346227, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346228, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346229, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346230, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346231, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346232, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346233, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346234, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346235, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346236, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346237, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346238, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346239, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346240, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346241, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346242, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346243, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346244, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346245, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346246, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346247, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346248, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346249, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346250, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346251, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346252, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346253, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346254, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346255, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346256, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346257, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346258, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346259, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346260, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346261, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346262, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346263, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346264, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346265, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346266, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346267, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346268, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346269, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346270, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346271, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346272, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346273, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346274, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346275, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346276, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346277, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346278, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346279, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346280, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346281, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346282, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346283, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346284, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346285, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346286, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346287, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346288, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346289, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346290, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346291, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346292, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346293, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346294, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346295, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346296, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346297, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346298, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346299, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346300, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346301, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346302, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346303, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346304, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346305, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346306, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346307, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346308, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346309, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346310, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346311, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346312, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346313, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346314, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346315, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346316, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346317, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346318, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346319, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346320, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346321, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346322, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346323, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346324, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346325, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346326, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346327, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346328, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346329, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346330, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346331, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346332, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346333, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346334, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346335, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346336, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346337, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346338, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346339, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346340, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346341, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346342, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346343, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346344, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346345, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346346, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346347, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346348, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346349, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346350, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346351, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346352, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346353, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346354, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346355, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346356, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346357, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346358, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346359, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346360, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346361, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346362, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346363, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346364, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346365, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346366, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346367, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346368, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346369, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346370, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346371, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346372, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346373, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346374, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346375, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346376, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346377, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346378, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346379, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346380, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346381, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346382, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346383, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346384, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346385, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346386, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346387, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346388, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346389, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346390, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346391, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346392, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346393, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346394, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346395, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346396, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346397, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346398, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346399, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346400, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346401, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346402, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346403, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346404, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346405, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346406, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346407, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346408, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346409, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346410, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346411, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346412, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346413, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346414, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346415, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346416, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346417, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346418, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346419, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346420, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346421, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346422, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346423, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346424, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346425, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346426, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346427, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346428, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346429, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346430, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346431, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346432, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346433, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346434, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346435, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346436, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346437, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346438, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346439, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346440, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346441, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346442, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346443, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346444, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346445, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346446, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346447, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346448, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346449, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346450, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346451, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346452, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346453, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346454, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346455, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346456, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346457, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346458, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346459, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346460, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346461, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346462, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346463, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346464, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346465, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346466, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346467, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346468, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346469, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346470, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346471, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346472, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346473, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346474, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346475, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346476, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346477, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346478, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346479, 'HP:0033394', 'Anti-carbonic anhydrase II antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346480, 'HP:0002901', 'Hypocalcemia', 'MP:0000195', 'decreased circulating calcium level', 0.4426229508196721, 15.87018167374507, 2.650378584745456, 'UPHENO:0034379', 'decreased level of calcium atom in blood'),
(346481, 'HP:0002901', 'Hypocalcemia', 'MP:0003020', 'decreased circulating chloride level', 0.4067796610169492, 12.062826751687464, 2.215155203807989, 'UPHENO:0051960', 'abnormal blood monoatomic ion level'),
(346482, 'HP:0008078', 'Thin metatarsal cortices', 'MP:0030825', 'decreased femur size', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(346483, 'HP:0008078', 'Thin metatarsal cortices', 'MP:0004635', 'short metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(346484, 'HP:0008078', 'Thin metatarsal cortices', 'MP:0030827', 'femur fracture', 0.43283582089552236, 7.694257931681313, 1.8249247787350484, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(346485, 'HP:0008078', 'Thin metatarsal cortices', 'MP:0008158', 'increased diameter of femur', 0.4142857142857143, 7.694257931681313, 1.7853910336744485, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(346486, 'HP:0008078', 'Thin metatarsal cortices', 'MP:0030823', 'increased femur size', 0.4264705882352941, 7.694257931681313, 1.8114565151165531, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(346487, 'HP:0008078', 'Thin metatarsal cortices', 'MP:0004642', 'fused metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(346488, 'HP:0008078', 'Thin metatarsal cortices', 'MP:0008152', 'decreased diameter of femur', 0.4142857142857143, 7.694257931681313, 1.7853910336744485, 'UPHENO:0079871', 'abnormal anatomical entity morphology in the skeleton of pelvic complex'),
(346489, 'HP:0008078', 'Thin metatarsal cortices', 'MP:0004641', 'elongated metatarsal bones', 0.45714285714285713, 11.548253578857707, 2.2976513303913713, 'UPHENO:0020817', 'abnormal metatarsal bone morphology'),
(346490, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009931', 'abnormal skin appearance', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346491, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001202', 'skin photosensitivity', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346492, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001243', 'abnormal dermal layer morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346493, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003717', 'pallor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346494, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001198', 'tight skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346495, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0005499', 'abnormal olfactory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346496, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001204', 'decreased sensitivity to skin irradiation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346497, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0014273', 'abnormal skin vasculature morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346498, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001209', 'spontaneous skin ulceration', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346499, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0031103', 'skin rash', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346500, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009604', 'increased keratohyalin granule number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346501, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009932', 'skin fibrosis', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346502, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0010285', 'decreased skin tumor incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346503, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0005501', 'abnormal skin physiology', 0.4074074074074074, 6.904974582545727, 1.6772411254464874, 'UPHENO:0003811', 'abnormal skin of body'),
(346504, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0013406', 'abnormal epidermal immune compartment', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346505, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0010016', 'variable depigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346506, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001231', 'abnormal epidermis stratum basale morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346507, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001201', 'translucent skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346508, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0005174', 'abnormal tail pigmentation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346509, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001211', 'wrinkled skin', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346510, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009563', 'dyskeratosis', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346511, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009827', 'skin detachment', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346512, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009610', 'abnormal epidermis stratum lucidum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346513, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0000367', 'abnormal coat/ hair morphology', 0.42857142857142855, 6.904974582545727, 1.7202542896592428, 'UPHENO:0003811', 'abnormal skin of body'),
(346514, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346515, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0008438', 'abnormal cutaneous collagen fibril morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346516, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001236', 'abnormal epidermis stratum spinosum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346517, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0002060', 'abnormal skin morphology', 0.5416666666666666, 7.4735768925632104, 2.012010806002726, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346518, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0011515', 'purpura', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346519, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009826', 'abnormal dermis reticular layer collagen network', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346520, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0014134', 'abnormal embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346521, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0005421', 'loose skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346522, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001210', 'skin ridges', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346523, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0002897', 'blotchy skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346524, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0011239', 'abnormal skin coloration', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346525, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0008816', 'petechiae', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346526, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001191', 'abnormal skin condition', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346527, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003196', 'calcified skin', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346528, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001208', 'blistering', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346529, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009603', 'absent keratohyalin granules', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346530, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0008854', 'bleb', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346531, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009545', 'abnormal dermis papillary layer morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346532, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009602', 'abnormal keratohyalin granule morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346533, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0005500', 'abnormal gustatory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346534, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001230', 'epidermal desquamation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346535, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0000377', 'abnormal hair follicle morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346536, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0010232', 'delayed skin pigmentation appearance', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346537, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001216', 'abnormal epidermal layer morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346538, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003652', 'abnormal skin turgor', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346539, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0005081', 'abnormal dermis reticular layer morphology', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346540, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009605', 'decreased keratohyalin granule number', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346541, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0004241', 'acantholysis', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346542, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003705', 'abnormal hypodermis morphology', 0.4230769230769231, 6.509554027552121, 1.6595306832293713, 'UPHENO:0002635', 'abnormal integument'),
(346543, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001196', 'shiny skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346544, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346545, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0010300', 'increased skin tumor incidence', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346546, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0031309', 'skin cyst', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346547, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009385', 'abnormal dermal pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346548, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009607', 'decreased keratohyalin granule size', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346549, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001239', 'abnormal epidermis stratum granulosum morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346550, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001212', 'skin lesions', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346551, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0011160', 'dermal-epidermal separation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346552, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0008419', 'abnormal cutaneous microfibril morphology', 0.4482758620689655, 7.4735768925632104, 1.8303617468283349, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346553, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0012248', 'absent dermatome', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346554, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0000574', 'abnormal foot pad morphology', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346555, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003653', 'decreased skin turgor', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346556, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001233', 'abnormal epidermis suprabasal layer morphology', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346557, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001195', 'flaky skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346558, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009441', 'delayed skin barrier formation', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346559, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0010206', 'pigment incontinence', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346560, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001246', 'mixed cellular infiltration to dermis', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346561, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001203', 'increased sensitivity to skin irradiation', 0.41935483870967744, 7.4735768925632104, 1.770333480552525, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346562, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009387', 'abnormal epidermal pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346563, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0002015', 'epithelioid cyst', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346564, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0008856', 'fetal bleb', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346565, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001193', 'psoriasis', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346566, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0008418', 'abnormal cutaneous elastic fiber morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346567, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003941', 'abnormal skin development', 0.52, 7.4735768925632104, 1.971359932669037, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346568, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0002163', 'abnormal gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346569, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346570, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001213', 'abnormal skin cell number', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346571, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003940', 'abnormal dermatome morphology', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346572, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0011159', 'abnormal epidermal-dermal junction morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346573, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0002095', 'abnormal skin pigmentation', 0.48148148148148145, 7.4735768925632104, 1.896941979660185, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346574, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003385', 'abnormal body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346575, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346576, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0003853', 'dry skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346577, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001192', 'scaly skin', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346578, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009606', 'increased keratohyalin granule size', 0.43333333333333335, 7.4735768925632104, 1.7995971734744949, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346579, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0002111', 'abnormal tail morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(346580, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0001197', 'oily skin', 0.40625, 7.4735768925632104, 1.7424524706871647, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346581, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0009379', 'abnormal foot pigmentation', 0.4642857142857143, 7.4735768925632104, 1.8627600451568955, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346582, 'HP:0010802', 'Perioral hyperpigmentation', 'MP:0012078', 'abnormal tail ring morphology', 0.5, 7.4735768925632104, 1.933077454806611, 'UPHENO:0076739', 'abnormal skin of body morphology'),
(346583, 'HP:0009136', 'Duplication involving bones of the feet', 'MP:0005109', 'abnormal talus morphology', 0.4117647058823529, 7.503859459499253, 1.7577896584413113, 'UPHENO:0081575', 'abnormal pes morphology'),
(346584, 'HP:0009136', 'Duplication involving bones of the feet', 'MP:0005353', 'abnormal patella morphology', 0.4166666666666667, 7.553673854641961, 1.7740812005375677, 'UPHENO:0003070', 'abnormal leg'),
(346585, 'HP:0009136', 'Duplication involving bones of the feet', 'MP:0009005', 'abnormal sesamoid bone of gastrocnemius morphology', 0.4166666666666667, 7.553673854641961, 1.7740812005375677, 'UPHENO:0003070', 'abnormal leg'),
(346586, 'HP:0009136', 'Duplication involving bones of the feet', 'MP:0002115', 'abnormal limb bone morphology', 0.40476190476190477, 6.179485229767373, 1.5815246479421996, 'UPHENO:0076727', 'abnormal limb bone morphology'),
(346587, 'HP:0009136', 'Duplication involving bones of the feet', 'MP:0003072', 'abnormal metatarsal bone morphology', 0.42, 7.503859459499253, 1.7752805336029813, 'UPHENO:0081575', 'abnormal pes morphology'),
(346588, 'HP:0009136', 'Duplication involving bones of the feet', 'MP:0009727', 'abnormal navicular morphology', 0.40384615384615385, 7.503859459499253, 1.7408057851813488, 'UPHENO:0081575', 'abnormal pes morphology'),
(346589, 'HP:0009136', 'Duplication involving bones of the feet', 'MP:0009728', 'abnormal calcaneum morphology', 0.40384615384615385, 7.503859459499253, 1.7408057851813488, 'UPHENO:0081575', 'abnormal pes morphology'),
(346590, 'HP:0009136', 'Duplication involving bones of the feet', 'MP:0005104', 'abnormal tarsal bone morphology', 0.42857142857142855, 7.503859459499253, 1.793304148313058, 'UPHENO:0081575', 'abnormal pes morphology'),
(346591, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0004602', 'abnormal vertebral articular process morphology', 0.4090909090909091, 10.700256672302757, 2.0922183752128745, 'UPHENO:0002992', 'abnormal arch of centrum of vertebra'),
(346592, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0004669', 'enlarged vertebral body', 0.43478260869565216, 10.93472192593978, 2.1804189790775634, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(346593, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0021136', 'abnormal vertebrae shape', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(346594, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0004610', 'small vertebrae', 0.4222222222222222, 8.941811350726098, 1.943046952390874, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(346595, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0000141', 'abnormal vertebral body morphology', 0.4146341463414634, 10.93472192593978, 2.129297792992639, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(346596, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0004670', 'small vertebral body', 0.425531914893617, 10.93472192593978, 2.157098319496442, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(346597, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0004599', 'abnormal vertebral arch morphology', 0.40476190476190477, 10.700256672302757, 2.0811189951856535, 'UPHENO:0002992', 'abnormal arch of centrum of vertebra'),
(346598, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(346599, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.40476190476190477, 8.941811350726098, 1.902447001716872, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(346600, 'HP:0008484', 'Thoracolumbar interpediculate narrowness', 'MP:0004600', 'abnormal vertebral transverse process morphology', 0.4090909090909091, 10.700256672302757, 2.0922183752128745, 'UPHENO:0002992', 'abnormal arch of centrum of vertebra'),
(346601, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0004101', 'abnormal brain interneuron morphology', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(346602, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0012138', 'decreased forebrain size', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(346603, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0020066', 'abnormal neocortex size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346604, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0013229', 'abnormal brain ventricle size', 0.42857142857142855, 6.72807461644252, 1.698075543049819, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(346605, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0020829', 'abnormal forebrain tissue architecture', 0.40540540540540543, 7.13344151829186, 1.7005692431238613, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346606, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0000831', 'diencephalon hyperplasia', 0.4222222222222222, 7.13344151829186, 1.7354819301696724, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346607, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0012775', 'abnormal brain weight', 0.4146341463414634, 6.213399309526074, 1.605081779406888, 'UPHENO:0076805', 'abnormal brain morphology'),
(346608, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0000783', 'abnormal forebrain morphology', 0.4166666666666667, 7.13344151829186, 1.724026478708571, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346609, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0000774', 'decreased brain size', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(346610, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0011854', 'cerebral edema', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(346611, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0000791', 'delaminated cerebral cortex', 0.4222222222222222, 7.13344151829186, 1.7354819301696724, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346612, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0030014', 'calcified brain', 0.4473684210526316, 6.213399309526074, 1.6672368273500293, 'UPHENO:0076805', 'abnormal brain morphology'),
(346613, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0012262', 'abnormal hindbrain size', 0.4186046511627907, 6.72807461644252, 1.6782143271385654, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(346614, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0012139', 'increased forebrain size', 0.425531914893617, 9.371930806217245, 1.997011683045471, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(346615, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0020569', 'abnormal premotor cortex size', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346616, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0020530', 'disorganized thalamus', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346617, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0000785', 'telencephalon hypoplasia', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346618, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0020557', 'abnormal ventromedial hypothalamic nucleus size', 0.40816326530612246, 9.821422361825213, 2.0021847619920465, 'UPHENO:0086740', 'abnormal limbic system morphology'),
(346619, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0012092', 'diencephalon hypoplasia', 0.40425531914893614, 7.13344151829186, 1.6981553749899763, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346620, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0012137', 'abnormal forebrain size', 0.4878048780487805, 9.371930806217245, 2.1381472269253146, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(346621, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0020525', 'abnormal thalamus size', 0.4318181818181818, 7.13344151829186, 1.7550925179417527, 'UPHENO:0087518', 'abnormal forebrain morphology'),
(346622, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0012088', 'abnormal midbrain size', 0.4090909090909091, 6.72807461644252, 1.6590341049152486, 'UPHENO:0081435', 'abnormal anatomical entity morphology in the brain'),
(346623, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0000771', 'abnormal brain size', 0.4473684210526316, 6.213399309526074, 1.6672368273500293, 'UPHENO:0076805', 'abnormal brain morphology'),
(346624, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0005238', 'increased brain size', 0.40476190476190477, 6.213399309526074, 1.5858585496727247, 'UPHENO:0076805', 'abnormal brain morphology'),
(346625, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0000839', 'hypothalamus hyperplasia', 0.40816326530612246, 9.821422361825213, 2.0021847619920465, 'UPHENO:0086740', 'abnormal limbic system morphology'),
(346626, 'HP:0033668', 'Abnormal amygdala morphology', 'MP:0004166', 'abnormal limbic system morphology', 0.43243243243243246, 9.821422361825213, 2.060849718409948, 'UPHENO:0086740', 'abnormal limbic system morphology'),
(346627, 'HP:0000621', 'Entropion', 'MP:0030167', 'decreased inner canthal distance', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346628, 'HP:0000621', 'Entropion', 'MP:0006166', 'eyelid retraction', 0.4583333333333333, 10.404207209241001, 2.1837112837786328, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346629, 'HP:0000621', 'Entropion', 'MP:0031290', 'bilateral microphthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346630, 'HP:0000621', 'Entropion', 'MP:0013395', 'eyelid hypoplasia', 0.4230769230769231, 10.404207209241001, 2.0980419378888553, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346631, 'HP:0000621', 'Entropion', 'MP:0009274', 'buphthalmos', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346632, 'HP:0000621', 'Entropion', 'MP:0006248', 'lagophthalmos', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346633, 'HP:0000621', 'Entropion', 'MP:0004874', 'abnormal timing of postnatal eyelid opening', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346634, 'HP:0000621', 'Entropion', 'MP:0003102', 'sclera thinning', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346635, 'HP:0000621', 'Entropion', 'MP:0012535', 'abnormal optic fissure closure', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346636, 'HP:0000621', 'Entropion', 'MP:0013442', 'abnormal Harderian gland size', 0.4074074074074074, 9.175301480945878, 1.9334129896464194, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(346637, 'HP:0000621', 'Entropion', 'MP:0030163', 'abnormal canthus morphology', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346638, 'HP:0000621', 'Entropion', 'MP:0001290', 'delayed eyelid opening', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346639, 'HP:0000621', 'Entropion', 'MP:0013744', 'abnormal conjunctival sac morphology', 0.40425531914893614, 9.175301480945878, 1.9259191126492001, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(346640, 'HP:0000621', 'Entropion', 'MP:0030164', 'abnormal inner canthus morphology', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346641, 'HP:0000621', 'Entropion', 'MP:0002092', 'abnormal eye morphology', 0.42857142857142855, 6.679863125803252, 1.6919806389220615, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346642, 'HP:0000621', 'Entropion', 'MP:0005262', 'coloboma', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346643, 'HP:0000621', 'Entropion', 'MP:0006165', 'entropion', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346644, 'HP:0000621', 'Entropion', 'MP:0006225', 'ocular rupture', 0.45652173913043476, 6.679863125803252, 1.74628254625217, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346645, 'HP:0000621', 'Entropion', 'MP:0006163', 'ankyloblepharon filiform', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346646, 'HP:0000621', 'Entropion', 'MP:0010081', 'posterior microphthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346647, 'HP:0000621', 'Entropion', 'MP:0030165', 'abnormal outer canthus morphology', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346648, 'HP:0000621', 'Entropion', 'MP:0013754', 'abnormal ocular surface morphology', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346649, 'HP:0000621', 'Entropion', 'MP:0011496', 'abnormal head size', 0.40476190476190477, 4.6730878730104815, 1.3753137636915733, 'UPHENO:0087907', 'abnormal head morphology'),
(346650, 'HP:0000621', 'Entropion', 'MP:0030063', 'abnormal face size', 0.4318181818181818, 5.913369942082322, 1.5979676645064742, 'UPHENO:0087472', 'abnormal face morphology'),
(346651, 'HP:0000621', 'Entropion', 'MP:0001297', 'microphthalmia', 0.42, 6.679863125803252, 1.674975376785392, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346652, 'HP:0000621', 'Entropion', 'MP:0008841', 'ruptured lens capsule', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346653, 'HP:0000621', 'Entropion', 'MP:0030071', 'abnormal face shape', 0.40425531914893614, 5.913369942082322, 1.5461278256283388, 'UPHENO:0087472', 'abnormal face morphology'),
(346654, 'HP:0000621', 'Entropion', 'MP:0001302', 'eyelids open at birth', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346655, 'HP:0000621', 'Entropion', 'MP:0001296', 'macrophthalmia', 0.42, 6.679863125803252, 1.674975376785392, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346656, 'HP:0000621', 'Entropion', 'MP:0001286', 'abnormal eye development', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346657, 'HP:0000621', 'Entropion', 'MP:0006168', 'epicanthus inversus', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346658, 'HP:0000621', 'Entropion', 'MP:0001344', 'blepharoptosis', 0.4318181818181818, 10.404207209241001, 2.119605114249838, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346659, 'HP:0000621', 'Entropion', 'MP:0006209', 'calcified intraocular region', 0.45652173913043476, 6.679863125803252, 1.74628254625217, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346660, 'HP:0000621', 'Entropion', 'MP:0005287', 'narrow eye opening', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346661, 'HP:0000621', 'Entropion', 'MP:0013396', 'eyelid hyperplasia', 0.4489795918367347, 10.404207209241001, 2.1613136528948864, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346662, 'HP:0000621', 'Entropion', 'MP:0006198', 'enophthalmos', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346663, 'HP:0000621', 'Entropion', 'MP:0013449', 'abnormal lacrimal lake morphology', 0.40425531914893614, 9.175301480945878, 1.9259191126492001, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(346664, 'HP:0000621', 'Entropion', 'MP:0003671', 'abnormal eyelid aperture', 0.46808510638297873, 10.404207209241001, 2.206819983226572, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346665, 'HP:0000621', 'Entropion', 'MP:0001343', 'pronounced eyelids', 0.43478260869565216, 10.404207209241001, 2.126868202744099, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346666, 'HP:0000621', 'Entropion', 'MP:0013146', 'eye lesions', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346667, 'HP:0000621', 'Entropion', 'MP:0006249', 'phthisis bulbi', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346668, 'HP:0000621', 'Entropion', 'MP:0006162', 'thick eyelids', 0.43137254901960786, 10.404207209241001, 2.1185111244405754, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346669, 'HP:0000621', 'Entropion', 'MP:0002697', 'abnormal eye size', 0.45652173913043476, 6.679863125803252, 1.74628254625217, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346670, 'HP:0000621', 'Entropion', 'MP:0001340', 'abnormal eyelid morphology', 0.4418604651162791, 10.404207209241001, 2.1441100337066126, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346671, 'HP:0000621', 'Entropion', 'MP:0006164', 'ectropion', 0.46808510638297873, 10.404207209241001, 2.206819983226572, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346672, 'HP:0000621', 'Entropion', 'MP:0001299', 'abnormal eye distance/ position', 0.41304347826086957, 6.679863125803252, 1.6610460257886595, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346673, 'HP:0000621', 'Entropion', 'MP:0001306', 'small lens', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346674, 'HP:0000621', 'Entropion', 'MP:0009263', 'abnormal eyelid fusion', 0.41304347826086957, 10.404207209241001, 2.073014697066019, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346675, 'HP:0000621', 'Entropion', 'MP:0009264', 'failure of eyelid fusion', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346676, 'HP:0000621', 'Entropion', 'MP:0005176', 'eyelids fail to open', 0.4583333333333333, 10.404207209241001, 2.1837112837786328, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346677, 'HP:0000621', 'Entropion', 'MP:0030166', 'increased inner canthal distance', 0.41509433962264153, 10.404207209241001, 2.078154835621499, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346678, 'HP:0000621', 'Entropion', 'MP:0013451', 'nasolacrimal duct obstruction', 0.41509433962264153, 9.175301480945878, 1.9515675005164117, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(346679, 'HP:0000621', 'Entropion', 'MP:0001305', 'enlarged lens', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346680, 'HP:0000621', 'Entropion', 'MP:0031289', 'unilateral microphthalmia', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346681, 'HP:0000621', 'Entropion', 'MP:0008855', 'eye bleb', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346682, 'HP:0000621', 'Entropion', 'MP:0009265', 'delayed eyelid fusion', 0.40425531914893614, 10.404207209241001, 2.05084277941128, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346683, 'HP:0000621', 'Entropion', 'MP:0009651', 'abnormal eyelid development', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346684, 'HP:0000621', 'Entropion', 'MP:0003153', 'early eyelid opening', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346685, 'HP:0000621', 'Entropion', 'MP:0008968', 'abnormal lacrimal apparatus morphology', 0.41304347826086957, 9.175301480945878, 1.9467404649264353, 'UPHENO:0075878', 'abnormal ocular adnexa'),
(346686, 'HP:0000621', 'Entropion', 'MP:0013745', 'abnormal eyelid margin morphology', 0.4222222222222222, 10.404207209241001, 2.095921632205317, 'UPHENO:0076761', 'abnormal eyelid morphology'),
(346687, 'HP:0000621', 'Entropion', 'MP:0009859', 'eye opacity', 0.4186046511627907, 6.679863125803252, 1.6721907108915715, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346688, 'HP:0000621', 'Entropion', 'MP:0030041', 'abnormal forehead size', 0.41304347826086957, 5.913369942082322, 1.5628432068256108, 'UPHENO:0087472', 'abnormal face morphology'),
(346689, 'HP:0000621', 'Entropion', 'MP:0005254', 'strabismus', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346690, 'HP:0000621', 'Entropion', 'MP:0013477', 'abnormal cornea limbus morphology', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(346691, 'HP:0032123', 'Ultra-low vision', 'MP:0004022', 'abnormal cone electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346692, 'HP:0032123', 'Ultra-low vision', 'MP:0011832', 'abnormal visual acuity', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346693, 'HP:0032123', 'Ultra-low vision', 'MP:0006150', 'double vision', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346694, 'HP:0032123', 'Ultra-low vision', 'MP:0031497', 'increased visual acuity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346695, 'HP:0032123', 'Ultra-low vision', 'MP:0020975', 'abnormal FO-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346696, 'HP:0032123', 'Ultra-low vision', 'MP:0013145', 'eye discharge', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346697, 'HP:0032123', 'Ultra-low vision', 'MP:0012037', 'abnormal b-wave latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346698, 'HP:0032123', 'Ultra-low vision', 'MP:0004021', 'abnormal rod electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346699, 'HP:0032123', 'Ultra-low vision', 'MP:0006153', 'hypermetropia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346700, 'HP:0032123', 'Ultra-low vision', 'MP:0005258', 'ocular hypertension', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346701, 'HP:0032123', 'Ultra-low vision', 'MP:0012031', 'abnormal b-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346702, 'HP:0032123', 'Ultra-low vision', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346703, 'HP:0032123', 'Ultra-low vision', 'MP:0020220', 'decreased tear production', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346704, 'HP:0032123', 'Ultra-low vision', 'MP:0006190', 'retina ischemia', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346705, 'HP:0032123', 'Ultra-low vision', 'MP:0005260', 'ocular hypotension', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346706, 'HP:0032123', 'Ultra-low vision', 'MP:0001999', 'photosensitivity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346707, 'HP:0032123', 'Ultra-low vision', 'MP:0006149', 'decreased visual acuity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346708, 'HP:0032123', 'Ultra-low vision', 'MP:0014157', 'alacrima', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346709, 'HP:0032123', 'Ultra-low vision', 'MP:0020978', 'abnormal FO-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346710, 'HP:0032123', 'Ultra-low vision', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346711, 'HP:0032123', 'Ultra-low vision', 'MP:0020860', 'abnormal cornea physiology', 0.43902439024390244, 8.795504987450572, 1.9650550155155173, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346712, 'HP:0032123', 'Ultra-low vision', 'MP:0020218', 'abnormal tear production', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346713, 'HP:0032123', 'Ultra-low vision', 'MP:0020439', 'absent b-wave', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346714, 'HP:0032123', 'Ultra-low vision', 'MP:0008145', 'hemeralopia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346715, 'HP:0032123', 'Ultra-low vision', 'MP:0003096', 'increased corneal light-scattering', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346716, 'HP:0032123', 'Ultra-low vision', 'MP:0010748', 'abnormal visual evoked potential', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346717, 'HP:0032123', 'Ultra-low vision', 'MP:0012036', 'abnormal a-wave latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346718, 'HP:0032123', 'Ultra-low vision', 'MP:0020958', 'abnormal c-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346719, 'HP:0032123', 'Ultra-low vision', 'MP:0005551', 'abnormal eye electrophysiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346720, 'HP:0032123', 'Ultra-low vision', 'MP:0020219', 'increased tear production', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346721, 'HP:0032123', 'Ultra-low vision', 'MP:0010749', 'absent visual evoked potential', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346722, 'HP:0032123', 'Ultra-low vision', 'MP:0005257', 'abnormal intraocular pressure', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346723, 'HP:0032123', 'Ultra-low vision', 'MP:0006152', 'tunnel vision', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346724, 'HP:0032123', 'Ultra-low vision', 'MP:0012034', 'abnormal a-wave shape', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346725, 'HP:0032123', 'Ultra-low vision', 'MP:0005253', 'abnormal eye physiology', 0.4358974358974359, 8.795504987450572, 1.9580444508368071, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346726, 'HP:0032123', 'Ultra-low vision', 'MP:0003011', 'delayed dark adaptation', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346727, 'HP:0032123', 'Ultra-low vision', 'MP:0012030', 'abnormal a-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346728, 'HP:0032123', 'Ultra-low vision', 'MP:0012039', 'abnormal b-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346729, 'HP:0032123', 'Ultra-low vision', 'MP:0020974', 'abnormal FO-wave shape', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346730, 'HP:0032123', 'Ultra-low vision', 'MP:0012038', 'abnormal a-wave implicit time', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346731, 'HP:0032123', 'Ultra-low vision', 'MP:0014132', 'abnormal tear film physiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346732, 'HP:0032123', 'Ultra-low vision', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346733, 'HP:0032123', 'Ultra-low vision', 'MP:0012033', 'abnormal ERG implicit time', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346734, 'HP:0032123', 'Ultra-low vision', 'MP:0001337', 'dry eyes', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346735, 'HP:0032123', 'Ultra-low vision', 'MP:0012035', 'abnormal b-wave shape', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346736, 'HP:0032123', 'Ultra-low vision', 'MP:0012040', 'abnormal c-wave shape', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346737, 'HP:0032123', 'Ultra-low vision', 'MP:0003100', 'myopia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346738, 'HP:0032123', 'Ultra-low vision', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346739, 'HP:0032123', 'Ultra-low vision', 'MP:0020961', 'abnormal c-wave amplitude', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346740, 'HP:0032123', 'Ultra-low vision', 'MP:0003101', 'high myopia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346741, 'HP:0032123', 'Ultra-low vision', 'MP:0013468', 'chromodacryorrhea', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346742, 'HP:0032123', 'Ultra-low vision', 'MP:0002090', 'abnormal vision', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346743, 'HP:0032123', 'Ultra-low vision', 'MP:0012032', 'abnormal ERG latency', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346744, 'HP:0032123', 'Ultra-low vision', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(346745, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000352', 'decreased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346746, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346747, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346748, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020097', 'low mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346749, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003077', 'abnormal cell cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346750, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346751, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346752, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346753, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346754, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346755, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031054', 'bronchiolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346756, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346757, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011082', 'abnormal gastrointestinal motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346758, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0006001', 'abnormal intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346759, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346760, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004145', 'abnormal muscle electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346761, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346762, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346763, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001862', 'interstitial pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346764, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005005', 'abnormal self tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346765, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030951', 'abnormal endocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346766, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346767, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346768, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346769, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005088', 'increased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346770, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346771, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003659', 'abnormal lymph circulation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346772, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346773, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031095', 'pharyngitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346774, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346775, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346776, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346777, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346778, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004036', 'abnormal muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346779, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004751', 'increased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346780, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008744', 'abnormal B cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346781, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008544', 'impaired olfaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346782, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346783, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000350', 'abnormal cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346784, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012554', 'increased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346785, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010680', 'abnormal skin adnexa physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346786, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012382', 'abnormal blood cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346787, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031009', 'abnormal sperm-egg fusion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346788, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031102', 'rhinorrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346789, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011717', 'increased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346790, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346791, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346792, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001876', 'decreased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346793, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346794, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008678', 'increased interleukin-16 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346795, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346796, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003926', 'decreased cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346797, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012111', 'failure of morula compaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346798, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002418', 'increased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346799, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011048', 'decreased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346800, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0006082', 'CNS inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346801, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003412', 'abnormal afterhyperpolarization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346802, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002635', 'reduced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346803, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346804, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346805, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008694', 'decreased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346806, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346807, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001841', 'decreased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346808, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346809, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346810, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001844', 'autoimmune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346811, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031092', 'dysgeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346812, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001986', 'abnormal taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346813, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012555', 'decreased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346814, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002498', 'abnormal acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346815, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346816, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346817, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346818, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346819, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002634', 'abnormal sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346820, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346821, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346822, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346823, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008690', 'increased interleukin-23 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346824, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013971', 'blood in lymph vessels', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346825, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346826, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008666', 'increased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346827, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346828, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003298', 'choking', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346829, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346830, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346831, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346832, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346833, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346834, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346835, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346836, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346837, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003866', 'abnormal defecation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346838, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011047', 'increased lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346839, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020154', 'impaired humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346840, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346841, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013636', 'abnormal bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346842, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005399', 'increased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346843, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020846', 'abnormal cell motility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346844, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008699', 'increased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346845, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346846, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346847, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346848, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346849, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010922', 'alveolitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346850, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008711', 'increased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346851, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346852, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346853, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008775', 'abnormal heart ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346854, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346855, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346856, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031223', 'increased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346857, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008693', 'increased interleukin-23a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346858, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008667', 'decreased interleukin-12a secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346859, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001790', 'abnormal immune system physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346860, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031110', 'meningitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346861, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346862, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020040', 'decreased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346863, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001819', 'abnormal immune cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346864, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003470', 'abnormal summary potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346865, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003925', 'abnormal cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346866, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002499', 'chronic inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346867, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346868, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346869, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002254', 'reproductive system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346870, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346871, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346872, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005363', 'decreased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346873, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001869', 'pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346874, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009473', 'abnormal skin exfoliation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346875, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008006', 'increased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346876, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346877, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346878, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031402', 'decreased muscle fatigability', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346879, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000501', 'abnormal digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346880, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002106', 'abnormal muscle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346881, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346882, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001663', 'abnormal digestive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346883, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001756', 'abnormal urination', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346884, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020001', 'decreased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346885, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346886, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346887, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346888, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346889, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346890, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005410', 'abnormal fertilization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346891, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005402', 'abnormal action potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346892, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346893, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346894, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031088', 'coughing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346895, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346896, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346897, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346898, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346899, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346900, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346901, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011431', 'increased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346902, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346903, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346904, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010143', 'enhanced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346905, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346906, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346907, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346908, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031170', 'abnormal vasculature physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346909, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011046', 'abnormal lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346910, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005364', 'increased susceptibility to prion infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346911, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346912, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346913, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008675', 'increased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346914, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346915, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346916, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346917, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003186', 'abnormal redox activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346918, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346919, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001636', 'irregular heartbeat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346920, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346921, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005043', 'defective assembly of class II molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346922, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346923, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346924, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011763', 'urethritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346925, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346926, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346927, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346928, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346929, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011432', 'decreased urine flow rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346930, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011926', 'abnormal heart valve physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346931, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010950', 'abnormal lung hysteresivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346932, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346933, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012553', 'decreased serum complement activity', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346934, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346935, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003280', 'urinary incontinence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346936, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346937, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003762', 'abnormal immune organ physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346938, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008681', 'increased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346939, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003767', 'palate inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346940, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346941, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005501', 'abnormal skin physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346942, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030130', 'gum inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346943, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346944, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001835', 'abnormal antigen presentation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346945, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031169', 'abnormal joint physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346946, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346947, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346948, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346949, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020039', 'increased bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346950, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010539', 'decreased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346951, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003875', 'abnormal hair follicle regression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346952, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346953, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346954, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005275', 'abnormal skin tensile strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346955, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346956, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346957, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003889', 'enhanced sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346958, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009062', 'impaired lectin complement pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346959, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346960, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346961, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000313', 'abnormal cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346962, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346963, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346964, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003009', 'abnormal cytokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346965, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020142', 'increased anti-sperm antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346966, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346967, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346968, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346969, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346970, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003157', 'impaired muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346971, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346972, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346973, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346974, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002409', 'decreased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346975, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346976, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346977, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030214', 'muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346978, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346979, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346980, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346981, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001633', 'poor circulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346982, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020096', 'high mean heart rate adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346983, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346984, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346985, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346986, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004212', 'abnormal salty taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346987, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000743', 'muscle spasm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346988, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346989, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346990, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346991, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002419', 'abnormal innate immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346992, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001761', 'abnormal urination pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346993, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005042', 'abnormal level of surface class II molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346994, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001950', 'abnormal respiratory sounds', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346995, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346996, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346997, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004945', 'abnormal bone resorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(346998, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011012', 'bronchiectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(346999, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347000, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002933', 'joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347001, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011044', 'increased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347002, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347003, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020381', 'muscle gating pore current', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347004, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347005, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004796', 'increased anti-histone antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347006, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003777', 'lip inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347007, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002161', 'abnormal fertility/fecundity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347008, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347009, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347010, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013639', 'decreased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347011, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001629', 'abnormal heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347012, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000738', 'impaired muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347013, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001648', 'abnormal apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347014, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347015, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347016, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008005', 'decreased stomach pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347017, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003746', 'stomatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347018, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347019, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000304', 'abnormal cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347020, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013942', 'enthesitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347021, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004211', 'abnormal sour taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347022, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347023, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001839', 'abnormal level of surface class I molecules', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347024, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005190', 'osteomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347025, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011045', 'decreased lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347026, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008558', 'abnormal interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347027, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347028, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031240', 'abnormal CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347029, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001840', 'increased level of surface class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347030, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001666', 'abnormal intestinal absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347031, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002406', 'increased susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347032, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002896', 'abnormal bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347033, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004046', 'abnormal mitosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347034, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031090', 'ageusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347035, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347036, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004994', 'abnormal brain wave pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347037, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008861', 'abnormal hair shedding', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347038, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347039, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347040, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347041, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008672', 'increased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347042, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002472', 'impaired complement alternative pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347043, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001864', 'vascular inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347044, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347045, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003303', 'peritoneal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347046, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347047, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001872', 'sinus inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347048, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001867', 'rhinitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347049, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0014037', 'stranguria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347050, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347051, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347052, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009046', 'muscle twitch', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347053, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347054, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002128', 'abnormal blood circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347055, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347056, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347057, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347058, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001664', 'abnormal digestion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347059, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004558', 'delayed allantois development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347060, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347061, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002998', 'abnormal bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347062, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347063, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347064, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347065, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008562', 'increased interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347066, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020371', 'abnormal glymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347067, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347068, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012006', 'abnormal hippocampus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347069, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011925', 'abnormal heart echocardiography feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347070, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001921', 'reduced fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347071, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002471', 'abnormal complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347072, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347073, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002420', 'abnormal adaptive immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347074, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347075, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347076, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347077, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030909', 'abnormal melanocyte adhesion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347078, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008271', 'abnormal bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347079, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003633', 'abnormal nervous system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347080, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347081, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347082, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005087', 'decreased acute inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347083, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347084, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031128', 'cardiovascular shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347085, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012565', 'perivasculitis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347086, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002500', 'granulomatous inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347087, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001542', 'abnormal bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347088, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001533', 'abnormal skeleton physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347089, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002322', 'abnormal respiratory transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347090, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347091, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347092, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009562', 'abnormal odor adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347093, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347094, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003726', 'decreased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347095, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347096, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005671', 'abnormal response to transplant', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347097, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347098, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347099, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347100, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347101, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347102, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347103, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005403', 'abnormal nerve conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347104, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347105, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347106, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347107, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008747', 'abnormal T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347108, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347109, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005620', 'abnormal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347110, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0006080', 'brain ischemia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347111, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347112, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347113, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347114, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009697', 'abnormal copulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347115, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347116, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347117, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003927', 'increased cellular glucose import', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347118, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347119, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347120, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005000', 'abnormal immune tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347121, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347122, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0006138', 'congestive heart failure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347123, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020386', 'adipose tissue inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347124, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347125, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347126, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004143', 'muscle hypertonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347127, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004752', 'decreased length of allograft survival', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347128, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347129, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031055', 'bronchitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347130, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008705', 'increased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347131, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005532', 'abnormal vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347132, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013136', 'genital discharge', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347133, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347134, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347135, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004085', 'abnormal heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347136, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347137, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347138, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347139, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030990', 'nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347140, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347141, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347142, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008004', 'abnormal stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347143, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347144, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347145, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347146, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003278', 'esophageal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347147, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003865', 'lymph node inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347148, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347149, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001985', 'abnormal gustatory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347150, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347151, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347152, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008708', 'increased interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347153, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347154, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347155, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031222', 'decreased CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347156, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010381', 'abnormal dosage compensation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347157, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347158, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001924', 'infertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347159, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011762', 'renal/urinary system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347160, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347161, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001800', 'abnormal humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347162, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347163, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003725', 'increased autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347164, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008713', 'abnormal cytokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347165, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347166, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347167, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001933', 'abnormal litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347168, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003259', 'nausea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347169, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008669', 'increased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347170, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347171, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0021016', 'decreased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347172, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347173, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001947', 'abnormal mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347174, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347175, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347176, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347177, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347178, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347179, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347180, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347181, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347182, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347183, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347184, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347185, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002405', 'respiratory system inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347186, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001849', 'ear inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347187, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0009057', 'increased interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347188, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004009', 'abnormal diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347189, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008272', 'abnormal endochondral bone ossification', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347190, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001845', 'abnormal inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347191, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347192, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010071', 'abnormal pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347193, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347194, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010377', 'abnormal gut flora balance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347195, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003566', 'abnormal cell adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347196, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030129', 'tongue inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347197, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008696', 'increased interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347198, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347199, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347200, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347201, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347202, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030988', 'dysosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347203, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002133', 'abnormal respiratory system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347204, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347205, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347206, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347207, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347208, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002164', 'abnormal gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347209, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347210, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013561', 'abnormal endocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347211, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347212, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008555', 'abnormal interferon secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347213, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010752', 'impaired mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347214, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347215, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347216, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001914', 'hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347217, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347218, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347219, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347220, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347221, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347222, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347223, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347224, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347225, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008748', 'abnormal central T cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347226, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0014048', 'abnormal Peyers patch physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347227, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010822', 'pneumothorax', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347228, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013640', 'increased bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347229, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347230, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001627', 'abnormal cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347231, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013806', 'encephalopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347232, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347233, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347234, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347235, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347236, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347237, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001919', 'abnormal reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347238, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347239, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004512', 'anosmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347240, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347241, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010695', 'abnormal blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347242, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347243, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347244, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001847', 'brain inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347245, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347246, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005076', 'abnormal cell differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347247, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008751', 'abnormal interleukin level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347248, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020002', 'increased response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347249, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005621', 'abnormal cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347250, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0021015', 'increased tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347251, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347252, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000751', 'myopathy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347253, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008721', 'abnormal chemokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347254, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347255, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003463', 'abnormal single cell response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347256, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000427', 'abnormal hair cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347257, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347258, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347259, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004213', 'abnormal umami taste sensitivity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347260, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001837', 'defective assembly of class I molecules', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347261, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004072', 'abnormal frontal plane axis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347262, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347263, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347264, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347265, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031013', 'abnormal egg activation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347266, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008942', 'abnormal induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347267, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347268, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347269, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347270, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004510', 'myositis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347271, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347272, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347273, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020000', 'abnormal response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347274, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0031089', 'sneezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347275, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0011566', 'abnormal complement protein level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347276, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347277, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347278, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0000351', 'increased cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347279, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347280, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347281, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020155', 'enhanced humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347282, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347283, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347284, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347285, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0030991', 'optic nerve inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347286, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347287, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347288, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347289, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347290, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347291, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0003260', 'vomiting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347292, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347293, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347294, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0005001', 'abnormal clonal deletion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347295, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347296, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0010211', 'abnormal acute phase protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(347297, 'HP:0034167', 'Abnormal circulating interleukin 22 concentration', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347298, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011365', 'small metanephros', 0.48936170212765956, 13.285219173023913, 2.5497602765064014, 'UPHENO:0069110', 'decreased size of the kidney'),
(347299, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0003626', 'kidney medulla hypoplasia', 0.44680851063829785, 7.667568053596582, 1.850928054313641, 'UPHENO:0076779', 'abnormal kidney morphology'),
(347300, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011422', 'kidney medulla atrophy', 0.5319148936170213, 14.87018167374507, 2.8124137503318902, 'UPHENO:0014019', 'kidney atrophy'),
(347301, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011304', 'kidney papillary atrophy', 0.4230769230769231, 10.052558416233639, 2.0622816208731423, 'UPHENO:0013936', 'anatomical entity atrophy'),
(347302, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0003446', 'renal hypoplasia', 0.5, 13.285219173023913, 2.577326053589642, 'UPHENO:0069110', 'decreased size of the kidney'),
(347303, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011423', 'kidney cortex atrophy', 0.5319148936170213, 14.87018167374507, 2.8124137503318902, 'UPHENO:0014019', 'kidney atrophy'),
(347304, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0000526', 'small inner medullary pyramid', 0.44680851063829785, 7.667568053596582, 1.850928054313641, 'UPHENO:0076779', 'abnormal kidney morphology'),
(347305, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0003625', 'kidney medulla hyperplasia', 0.40425531914893614, 7.667568053596582, 1.7605837584741242, 'UPHENO:0076779', 'abnormal kidney morphology'),
(347306, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0002707', 'abnormal kidney weight', 0.46511627906976744, 12.548253578857707, 2.415863616478006, 'UPHENO:0075182', 'abnormal size of kidney'),
(347307, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011363', 'renal glomerulus atrophy', 0.46296296296296297, 14.87018167374507, 2.6238032257535187, 'UPHENO:0014019', 'kidney atrophy'),
(347308, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0003918', 'decreased kidney weight', 0.46938775510204084, 13.285219173023913, 2.4971822527929928, 'UPHENO:0069110', 'decreased size of the kidney'),
(347309, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0002990', 'short ureter', 0.4222222222222222, 7.390401409715969, 1.766463049804473, 'UPHENO:0087427', 'abnormal renal system morphology'),
(347310, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0003594', 'small urethra', 0.4090909090909091, 7.390401409715969, 1.738777165495177, 'UPHENO:0087427', 'abnormal renal system morphology'),
(347311, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0003985', 'renal fibrosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(347312, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011346', 'renal tubule atrophy', 0.5, 14.87018167374507, 2.726736297640924, 'UPHENO:0014019', 'kidney atrophy'),
(347313, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0004968', 'kidney epithelium hyperplasia', 0.41304347826086957, 7.667568053596582, 1.7796176495695522, 'UPHENO:0076779', 'abnormal kidney morphology'),
(347314, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0002955', 'increased compensatory renal growth', 0.4878048780487805, 12.548253578857707, 2.474085549604107, 'UPHENO:0075182', 'abnormal size of kidney'),
(347315, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0002706', 'abnormal kidney size', 0.5, 12.548253578857707, 2.5048207100367192, 'UPHENO:0075182', 'abnormal size of kidney'),
(347316, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0002989', 'small kidney', 0.5609756097560976, 13.285219173023913, 2.72996042578102, 'UPHENO:0069110', 'decreased size of the kidney'),
(347317, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0002269', 'muscular atrophy', 0.40476190476190477, 10.052558416233639, 2.0171496454861857, 'UPHENO:0013936', 'anatomical entity atrophy'),
(347318, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011360', 'kidney cortex hypoplasia', 0.44680851063829785, 7.667568053596582, 1.850928054313641, 'UPHENO:0076779', 'abnormal kidney morphology'),
(347319, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0004970', 'kidney atrophy', 0.5952380952380952, 14.87018167374507, 2.975113210505517, 'UPHENO:0014019', 'kidney atrophy'),
(347320, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011844', 'kidney collecting duct atrophy', 0.4583333333333333, 10.052558416233639, 2.146490765747763, 'UPHENO:0013936', 'anatomical entity atrophy'),
(347321, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0011298', 'ureter hypoplasia', 0.41304347826086957, 7.390401409715969, 1.7471568630243588, 'UPHENO:0087427', 'abnormal renal system morphology'),
(347322, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0003197', 'nephrocalcinosis', 0.42857142857142855, 7.667568053596582, 1.8127604900809524, 'UPHENO:0076779', 'abnormal kidney morphology'),
(347323, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0009641', 'kidney degeneration', 0.4186046511627907, 7.667568053596582, 1.7915578836149155, 'UPHENO:0076779', 'abnormal kidney morphology'),
(347324, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0003068', 'enlarged kidney', 0.425531914893617, 12.548253578857707, 2.3107752755259443, 'UPHENO:0075182', 'abnormal size of kidney'),
(347325, 'HP:0012586', 'Bilateral renal atrophy', 'MP:0002956', 'decreased compensatory renal growth', 0.4878048780487805, 12.548253578857707, 2.474085549604107, 'UPHENO:0075182', 'abnormal size of kidney'),
(347326, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0020205', 'abnormal heart right ventricle weight', 0.4067796610169492, 13.548253578857707, 2.3475847158685044, 'UPHENO:0075208', 'abnormal size of heart right ventricle'),
(347327, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0003914', 'decreased heart right ventricle weight', 0.4057971014492754, 15.384754846574829, 2.49861740233429, 'UPHENO:0068886', 'decreased size of the heart right ventricle'),
(347328, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0002740', 'heart hypoplasia', 0.4528301886792453, 14.192109768632433, 2.5350770687074555, 'UPHENO:0081262', 'heart hypoplasia'),
(347329, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0010422', 'heart right ventricle hypoplasia', 0.5689655172413793, 16.607147267911277, 3.073905355600738, 'UPHENO:0081174', 'heart right ventricle hypoplasia'),
(347330, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0000279', 'ventricular hypoplasia', 0.5185185185185185, 14.491670050491338, 2.741203984646154, 'UPHENO:0081176', 'cardiac ventricle hypoplasia'),
(347331, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0010446', 'heart left ventricle hypoplasia', 0.4444444444444444, 14.491670050491338, 2.537861746562018, 'UPHENO:0081176', 'cardiac ventricle hypoplasia'),
(347332, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0010502', 'ventricle myocardium hypoplasia', 0.4084507042253521, 14.491670050491338, 2.4329268048021158, 'UPHENO:0081176', 'cardiac ventricle hypoplasia'),
(347333, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0010577', 'abnormal heart right ventricle size', 0.4339622641509434, 13.548253578857707, 2.4247537603584024, 'UPHENO:0075208', 'abnormal size of heart right ventricle'),
(347334, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0010542', 'right ventricular myocardium hypoplasia', 0.4342105263157895, 15.384754846574829, 2.584612640062462, 'UPHENO:0068886', 'decreased size of the heart right ventricle'),
(347335, 'HP:0004762', 'Hypoplasia of right ventricle', 'MP:0003649', 'decreased heart right ventricle size', 0.48148148148148145, 15.384754846574829, 2.721667605670878, 'UPHENO:0068886', 'decreased size of the heart right ventricle'),
(347336, 'HP:0006528', 'Chronic lung disease', 'MP:0011938', 'prolonged PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347337, 'HP:0006528', 'Chronic lung disease', 'MP:0010753', 'improved mucociliary clearance', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347338, 'HP:0006528', 'Chronic lung disease', 'MP:0003475', 'increased summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347339, 'HP:0006528', 'Chronic lung disease', 'MP:0008691', 'decreased interleukin-23 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347340, 'HP:0006528', 'Chronic lung disease', 'MP:0006044', 'tricuspid valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347341, 'HP:0006528', 'Chronic lung disease', 'MP:0001837', 'defective assembly of class I molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347342, 'HP:0006528', 'Chronic lung disease', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347343, 'HP:0006528', 'Chronic lung disease', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347344, 'HP:0006528', 'Chronic lung disease', 'MP:0020000', 'abnormal response to antigen', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347345, 'HP:0006528', 'Chronic lung disease', 'MP:0003865', 'lymph node inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347346, 'HP:0006528', 'Chronic lung disease', 'MP:0013208', 'abnormal cilium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347347, 'HP:0006528', 'Chronic lung disease', 'MP:0005025', 'abnormal response to infection', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347348, 'HP:0006528', 'Chronic lung disease', 'MP:0003192', 'increased cholesterol efflux', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347349, 'HP:0006528', 'Chronic lung disease', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347350, 'HP:0006528', 'Chronic lung disease', 'MP:0021009', 'abnormal synaptic physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347351, 'HP:0006528', 'Chronic lung disease', 'MP:0005402', 'abnormal action potential', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347352, 'HP:0006528', 'Chronic lung disease', 'MP:0008407', 'decreased cellular sensitivity to hydrogen peroxide', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347353, 'HP:0006528', 'Chronic lung disease', 'MP:0011832', 'abnormal visual acuity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347354, 'HP:0006528', 'Chronic lung disease', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347355, 'HP:0006528', 'Chronic lung disease', 'MP:0003898', 'abnormal QRS complex', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347356, 'HP:0006528', 'Chronic lung disease', 'MP:0002841', 'impaired skeletal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347357, 'HP:0006528', 'Chronic lung disease', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347358, 'HP:0006528', 'Chronic lung disease', 'MP:0011399', 'increased endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347359, 'HP:0006528', 'Chronic lung disease', 'MP:0001945', 'bronchoconstriction', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347360, 'HP:0006528', 'Chronic lung disease', 'MP:0004046', 'abnormal mitosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347361, 'HP:0006528', 'Chronic lung disease', 'MP:0003889', 'enhanced sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347362, 'HP:0006528', 'Chronic lung disease', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347363, 'HP:0006528', 'Chronic lung disease', 'MP:0013557', 'abnormal merocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347364, 'HP:0006528', 'Chronic lung disease', 'MP:0002896', 'abnormal bone mineralization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347365, 'HP:0006528', 'Chronic lung disease', 'MP:0001756', 'abnormal urination', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347366, 'HP:0006528', 'Chronic lung disease', 'MP:0003621', 'dysuria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347367, 'HP:0006528', 'Chronic lung disease', 'MP:0002321', 'hypoventilation', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347368, 'HP:0006528', 'Chronic lung disease', 'MP:0013498', 'trachea inflammation', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347369, 'HP:0006528', 'Chronic lung disease', 'MP:0002406', 'increased susceptibility to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347370, 'HP:0006528', 'Chronic lung disease', 'MP:0004036', 'abnormal muscle relaxation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347371, 'HP:0006528', 'Chronic lung disease', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347372, 'HP:0006528', 'Chronic lung disease', 'MP:0004812', 'abnormal linear vestibular evoked potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347373, 'HP:0006528', 'Chronic lung disease', 'MP:0011919', 'abnormal R wave', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347374, 'HP:0006528', 'Chronic lung disease', 'MP:0001663', 'abnormal digestive system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347375, 'HP:0006528', 'Chronic lung disease', 'MP:0004512', 'anosmia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347376, 'HP:0006528', 'Chronic lung disease', 'MP:0014028', 'decreased respiratory epithelial chloride transmembrane transport', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347377, 'HP:0006528', 'Chronic lung disease', 'MP:0010950', 'abnormal lung hysteresivity', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347378, 'HP:0006528', 'Chronic lung disease', 'MP:0009045', 'muscle tetany', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347379, 'HP:0006528', 'Chronic lung disease', 'MP:0020848', 'abnormal exocytosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347380, 'HP:0006528', 'Chronic lung disease', 'MP:0008660', 'increased interleukin-10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347381, 'HP:0006528', 'Chronic lung disease', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347382, 'HP:0006528', 'Chronic lung disease', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347383, 'HP:0006528', 'Chronic lung disease', 'MP:0009645', 'crystalluria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347384, 'HP:0006528', 'Chronic lung disease', 'MP:0006114', 'cardiac murmur', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347385, 'HP:0006528', 'Chronic lung disease', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347386, 'HP:0006528', 'Chronic lung disease', 'MP:0004751', 'increased length of allograft survival', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347387, 'HP:0006528', 'Chronic lung disease', 'MP:0004021', 'abnormal rod electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347388, 'HP:0006528', 'Chronic lung disease', 'MP:0001866', 'nasal inflammation', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347389, 'HP:0006528', 'Chronic lung disease', 'MP:0011953', 'prolonged PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347390, 'HP:0006528', 'Chronic lung disease', 'MP:0020219', 'increased tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347391, 'HP:0006528', 'Chronic lung disease', 'MP:0003699', 'abnormal female reproductive system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347392, 'HP:0006528', 'Chronic lung disease', 'MP:0011758', 'renal ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347393, 'HP:0006528', 'Chronic lung disease', 'MP:0010752', 'impaired mucociliary clearance', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347394, 'HP:0006528', 'Chronic lung disease', 'MP:0009058', 'decreased interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347395, 'HP:0006528', 'Chronic lung disease', 'MP:0008711', 'increased interleukin-9 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347396, 'HP:0006528', 'Chronic lung disease', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347397, 'HP:0006528', 'Chronic lung disease', 'MP:0010822', 'pneumothorax', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347398, 'HP:0006528', 'Chronic lung disease', 'MP:0005036', 'diarrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347399, 'HP:0006528', 'Chronic lung disease', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347400, 'HP:0006528', 'Chronic lung disease', 'MP:0031102', 'rhinorrhea', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347401, 'HP:0006528', 'Chronic lung disease', 'MP:0009384', 'cardiac valve regurgitation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347402, 'HP:0006528', 'Chronic lung disease', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347403, 'HP:0006528', 'Chronic lung disease', 'MP:0001636', 'irregular heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347404, 'HP:0006528', 'Chronic lung disease', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347405, 'HP:0006528', 'Chronic lung disease', 'MP:0006265', 'increased pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347406, 'HP:0006528', 'Chronic lung disease', 'MP:0014275', 'increased respiration', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347407, 'HP:0006528', 'Chronic lung disease', 'MP:0010038', 'abnormal placenta physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347408, 'HP:0006528', 'Chronic lung disease', 'MP:0031014', 'polyspermy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347409, 'HP:0006528', 'Chronic lung disease', 'MP:0004037', 'increased muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347410, 'HP:0006528', 'Chronic lung disease', 'MP:0010634', 'increased QRS amplitude', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347411, 'HP:0006528', 'Chronic lung disease', 'MP:0003233', 'prolonged QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347412, 'HP:0006528', 'Chronic lung disease', 'MP:0020412', 'abnormal amnion physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347413, 'HP:0006528', 'Chronic lung disease', 'MP:0005573', 'increased pulmonary respiratory rate', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347414, 'HP:0006528', 'Chronic lung disease', 'MP:0030939', 'abnormal autophagosome formation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347415, 'HP:0006528', 'Chronic lung disease', 'MP:0006336', 'abnormal otoacoustic response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347416, 'HP:0006528', 'Chronic lung disease', 'MP:0005001', 'abnormal clonal deletion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347417, 'HP:0006528', 'Chronic lung disease', 'MP:0003823', 'increased left ventricle developed pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347418, 'HP:0006528', 'Chronic lung disease', 'MP:0003252', 'abnormal bile duct physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347419, 'HP:0006528', 'Chronic lung disease', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347420, 'HP:0006528', 'Chronic lung disease', 'MP:0005275', 'abnormal skin tensile strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347421, 'HP:0006528', 'Chronic lung disease', 'MP:0003868', 'abnormal feces composition', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347422, 'HP:0006528', 'Chronic lung disease', 'MP:0003925', 'abnormal cellular glucose uptake', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347423, 'HP:0006528', 'Chronic lung disease', 'MP:0009057', 'increased interleukin-21 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347424, 'HP:0006528', 'Chronic lung disease', 'MP:0000610', 'cholestasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347425, 'HP:0006528', 'Chronic lung disease', 'MP:0002320', 'hyperventilation', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347426, 'HP:0006528', 'Chronic lung disease', 'MP:0031104', 'crackles', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347427, 'HP:0006528', 'Chronic lung disease', 'MP:0002420', 'abnormal adaptive immunity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347428, 'HP:0006528', 'Chronic lung disease', 'MP:0002294', 'short gestation period', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347429, 'HP:0006528', 'Chronic lung disease', 'MP:0031055', 'bronchitis', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347430, 'HP:0006528', 'Chronic lung disease', 'MP:0001876', 'decreased inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347431, 'HP:0006528', 'Chronic lung disease', 'MP:0000738', 'impaired muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347432, 'HP:0006528', 'Chronic lung disease', 'MP:0002999', 'abnormal bone healing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347433, 'HP:0006528', 'Chronic lung disease', 'MP:0031480', 'abnormal urine xanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347434, 'HP:0006528', 'Chronic lung disease', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347435, 'HP:0006528', 'Chronic lung disease', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347436, 'HP:0006528', 'Chronic lung disease', 'MP:0003393', 'decreased cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347437, 'HP:0006528', 'Chronic lung disease', 'MP:0010094', 'abnormal chromosome stability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347438, 'HP:0006528', 'Chronic lung disease', 'MP:0004009', 'abnormal diastolic filling velocity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347439, 'HP:0006528', 'Chronic lung disease', 'MP:0031223', 'increased CXCL10 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347440, 'HP:0006528', 'Chronic lung disease', 'MP:0004211', 'abnormal sour taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347441, 'HP:0006528', 'Chronic lung disease', 'MP:0012035', 'abnormal b-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347442, 'HP:0006528', 'Chronic lung disease', 'MP:0031009', 'abnormal sperm-egg fusion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347443, 'HP:0006528', 'Chronic lung disease', 'MP:0008009', 'delayed cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347444, 'HP:0006528', 'Chronic lung disease', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347445, 'HP:0006528', 'Chronic lung disease', 'MP:0031126', 'gangrene', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347446, 'HP:0006528', 'Chronic lung disease', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347447, 'HP:0006528', 'Chronic lung disease', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347448, 'HP:0006528', 'Chronic lung disease', 'MP:0011925', 'abnormal heart echocardiography feature', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347449, 'HP:0006528', 'Chronic lung disease', 'MP:0020097', 'low mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347450, 'HP:0006528', 'Chronic lung disease', 'MP:0004486', 'decreased response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347451, 'HP:0006528', 'Chronic lung disease', 'MP:0002007', 'increased cellular sensitivity to gamma-irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347452, 'HP:0006528', 'Chronic lung disease', 'MP:0006080', 'brain ischemia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347453, 'HP:0006528', 'Chronic lung disease', 'MP:0012125', 'decreased bronchoconstrictive response', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347454, 'HP:0006528', 'Chronic lung disease', 'MP:0002128', 'abnormal blood circulation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347455, 'HP:0006528', 'Chronic lung disease', 'MP:0031479', 'increased urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347456, 'HP:0006528', 'Chronic lung disease', 'MP:0003483', 'decreased nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347457, 'HP:0006528', 'Chronic lung disease', 'MP:0005330', 'cardiomyopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347458, 'HP:0006528', 'Chronic lung disease', 'MP:0010381', 'abnormal dosage compensation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347459, 'HP:0006528', 'Chronic lung disease', 'MP:0009349', 'increased urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347460, 'HP:0006528', 'Chronic lung disease', 'MP:0001912', 'increased cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347461, 'HP:0006528', 'Chronic lung disease', 'MP:0012745', 'abnormal neural crest cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347462, 'HP:0006528', 'Chronic lung disease', 'MP:0003787', 'abnormal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347463, 'HP:0006528', 'Chronic lung disease', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347464, 'HP:0006528', 'Chronic lung disease', 'MP:0020414', 'abnormal fibroblast physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347465, 'HP:0006528', 'Chronic lung disease', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347466, 'HP:0006528', 'Chronic lung disease', 'MP:0008702', 'increased interleukin-5 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347467, 'HP:0006528', 'Chronic lung disease', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347468, 'HP:0006528', 'Chronic lung disease', 'MP:0001793', 'abnormal susceptibility to infection', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347469, 'HP:0006528', 'Chronic lung disease', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347470, 'HP:0006528', 'Chronic lung disease', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347471, 'HP:0006528', 'Chronic lung disease', 'MP:0000951', 'sporadic seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347472, 'HP:0006528', 'Chronic lung disease', 'MP:0030904', 'abnormal melanoblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347473, 'HP:0006528', 'Chronic lung disease', 'MP:0002578', 'impaired ability to fire action potentials', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347474, 'HP:0006528', 'Chronic lung disease', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347475, 'HP:0006528', 'Chronic lung disease', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347476, 'HP:0006528', 'Chronic lung disease', 'MP:0011043', 'abnormal lung elastance', 0.6086956521739131, 8.526773851447254, 2.278203276805245, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347477, 'HP:0006528', 'Chronic lung disease', 'MP:0011194', 'abnormal hair follicle physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347478, 'HP:0006528', 'Chronic lung disease', 'MP:0002893', 'ketoaciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347479, 'HP:0006528', 'Chronic lung disease', 'MP:0011044', 'increased lung elastance', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347480, 'HP:0006528', 'Chronic lung disease', 'MP:0020001', 'decreased response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347481, 'HP:0006528', 'Chronic lung disease', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347482, 'HP:0006528', 'Chronic lung disease', 'MP:0011951', 'increased cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347483, 'HP:0006528', 'Chronic lung disease', 'MP:0006043', 'decreased apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347484, 'HP:0006528', 'Chronic lung disease', 'MP:0008568', 'abnormal interleukin secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347485, 'HP:0006528', 'Chronic lung disease', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347486, 'HP:0006528', 'Chronic lung disease', 'MP:0012348', 'decreased susceptibility to induction of seizure by inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347487, 'HP:0006528', 'Chronic lung disease', 'MP:0010560', 'intraventricular block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347488, 'HP:0006528', 'Chronic lung disease', 'MP:0020846', 'abnormal cell motility', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347489, 'HP:0006528', 'Chronic lung disease', 'MP:0003547', 'abnormal pulmonary pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347490, 'HP:0006528', 'Chronic lung disease', 'MP:0005647', 'abnormal sex gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347491, 'HP:0006528', 'Chronic lung disease', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347492, 'HP:0006528', 'Chronic lung disease', 'MP:0030574', 'increased hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347493, 'HP:0006528', 'Chronic lung disease', 'MP:0013752', 'stridor', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347494, 'HP:0006528', 'Chronic lung disease', 'MP:0011927', 'abnormal cardiac valve flow', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347495, 'HP:0006528', 'Chronic lung disease', 'MP:0011824', 'increased cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347496, 'HP:0006528', 'Chronic lung disease', 'MP:0014029', 'increased respiratory epithelial chloride transmembrane transport', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347497, 'HP:0006528', 'Chronic lung disease', 'MP:0006332', 'abnormal cochlear potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347498, 'HP:0006528', 'Chronic lung disease', 'MP:0020080', 'increased bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347499, 'HP:0006528', 'Chronic lung disease', 'MP:0003467', 'abnormal single cell response intensity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347500, 'HP:0006528', 'Chronic lung disease', 'MP:0009643', 'abnormal urine homeostasis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347501, 'HP:0006528', 'Chronic lung disease', 'MP:0011432', 'decreased urine flow rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347502, 'HP:0006528', 'Chronic lung disease', 'MP:0004244', 'abnormal miscarriage rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347503, 'HP:0006528', 'Chronic lung disease', 'MP:0013638', 'decreased femur stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347504, 'HP:0006528', 'Chronic lung disease', 'MP:0003900', 'shortened QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347505, 'HP:0006528', 'Chronic lung disease', 'MP:0001984', 'abnormal olfaction', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347506, 'HP:0006528', 'Chronic lung disease', 'MP:0001924', 'infertility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347507, 'HP:0006528', 'Chronic lung disease', 'MP:0020039', 'increased bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347508, 'HP:0006528', 'Chronic lung disease', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347509, 'HP:0006528', 'Chronic lung disease', 'MP:0010946', 'hyperpnea', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347510, 'HP:0006528', 'Chronic lung disease', 'MP:0012033', 'abnormal ERG implicit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347511, 'HP:0006528', 'Chronic lung disease', 'MP:0001983', 'abnormal olfactory system physiology', 0.5217391304347826, 5.059610039003922, 1.6247450698768107, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347512, 'HP:0006528', 'Chronic lung disease', 'MP:0001846', 'increased inflammatory response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347513, 'HP:0006528', 'Chronic lung disease', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347514, 'HP:0006528', 'Chronic lung disease', 'MP:0002295', 'abnormal pulmonary circulation', 0.4117647058823529, 8.526773851447254, 1.873772805616123, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347515, 'HP:0006528', 'Chronic lung disease', 'MP:0004742', 'abnormal vestibular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347516, 'HP:0006528', 'Chronic lung disease', 'MP:0009275', 'bruising', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347517, 'HP:0006528', 'Chronic lung disease', 'MP:0012045', 'increased susceptibility to hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347518, 'HP:0006528', 'Chronic lung disease', 'MP:0011809', 'abnormal anoikis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347519, 'HP:0006528', 'Chronic lung disease', 'MP:0013632', 'increased femur maximal load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347520, 'HP:0006528', 'Chronic lung disease', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347521, 'HP:0006528', 'Chronic lung disease', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347522, 'HP:0006528', 'Chronic lung disease', 'MP:0020002', 'increased response to antigen', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347523, 'HP:0006528', 'Chronic lung disease', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347524, 'HP:0006528', 'Chronic lung disease', 'MP:0011421', 'cylindruria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347525, 'HP:0006528', 'Chronic lung disease', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347526, 'HP:0006528', 'Chronic lung disease', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347527, 'HP:0006528', 'Chronic lung disease', 'MP:0008706', 'decreased interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347528, 'HP:0006528', 'Chronic lung disease', 'MP:0014201', 'abnormal intestinal epithelium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347529, 'HP:0006528', 'Chronic lung disease', 'MP:0001935', 'decreased litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347530, 'HP:0006528', 'Chronic lung disease', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347531, 'HP:0006528', 'Chronic lung disease', 'MP:0013559', 'abnormal exocrine gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347532, 'HP:0006528', 'Chronic lung disease', 'MP:0031424', 'enhanced female fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347533, 'HP:0006528', 'Chronic lung disease', 'MP:0008663', 'increased interleukin-12 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347534, 'HP:0006528', 'Chronic lung disease', 'MP:0010936', 'decreased airway resistance', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347535, 'HP:0006528', 'Chronic lung disease', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347536, 'HP:0006528', 'Chronic lung disease', 'MP:0012746', 'abnormal neural crest cell delamination', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347537, 'HP:0006528', 'Chronic lung disease', 'MP:0008705', 'increased interleukin-6 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347538, 'HP:0006528', 'Chronic lung disease', 'MP:0003412', 'abnormal afterhyperpolarization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347539, 'HP:0006528', 'Chronic lung disease', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347540, 'HP:0006528', 'Chronic lung disease', 'MP:0003011', 'delayed dark adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347541, 'HP:0006528', 'Chronic lung disease', 'MP:0014031', 'abnormal submucosal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347542, 'HP:0006528', 'Chronic lung disease', 'MP:0008775', 'abnormal heart ventricle pressure', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347543, 'HP:0006528', 'Chronic lung disease', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347544, 'HP:0006528', 'Chronic lung disease', 'MP:0003123', 'paternal imprinting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347545, 'HP:0006528', 'Chronic lung disease', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347546, 'HP:0006528', 'Chronic lung disease', 'MP:0008676', 'decreased interleukin-15 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347547, 'HP:0006528', 'Chronic lung disease', 'MP:0005088', 'increased acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347548, 'HP:0006528', 'Chronic lung disease', 'MP:0006045', 'mitral valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347549, 'HP:0006528', 'Chronic lung disease', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347550, 'HP:0006528', 'Chronic lung disease', 'MP:0011937', 'shortened PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347551, 'HP:0006528', 'Chronic lung disease', 'MP:0003477', 'abnormal nerve fiber response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347552, 'HP:0006528', 'Chronic lung disease', 'MP:0010695', 'abnormal blood pressure regulation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347553, 'HP:0006528', 'Chronic lung disease', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347554, 'HP:0006528', 'Chronic lung disease', 'MP:0004212', 'abnormal salty taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347555, 'HP:0006528', 'Chronic lung disease', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347556, 'HP:0006528', 'Chronic lung disease', 'MP:0000316', 'cellular necrosis', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347557, 'HP:0006528', 'Chronic lung disease', 'MP:0010520', 'sinoatrial block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347558, 'HP:0006528', 'Chronic lung disease', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347559, 'HP:0006528', 'Chronic lung disease', 'MP:0001956', 'hypopnea', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347560, 'HP:0006528', 'Chronic lung disease', 'MP:0003116', 'rickets', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347561, 'HP:0006528', 'Chronic lung disease', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347562, 'HP:0006528', 'Chronic lung disease', 'MP:0031425', 'enhanced male fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347563, 'HP:0006528', 'Chronic lung disease', 'MP:0010748', 'abnormal visual evoked potential', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347564, 'HP:0006528', 'Chronic lung disease', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347565, 'HP:0006528', 'Chronic lung disease', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347566, 'HP:0006528', 'Chronic lung disease', 'MP:0001337', 'dry eyes', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347567, 'HP:0006528', 'Chronic lung disease', 'MP:0008685', 'decreased interleukin-18 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347568, 'HP:0006528', 'Chronic lung disease', 'MP:0030940', 'impaired autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347569, 'HP:0006528', 'Chronic lung disease', 'MP:0008567', 'decreased interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347570, 'HP:0006528', 'Chronic lung disease', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347571, 'HP:0006528', 'Chronic lung disease', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347572, 'HP:0006528', 'Chronic lung disease', 'MP:0005572', 'abnormal pulmonary respiratory rate', 0.5, 8.526773851447254, 2.0647970664749664, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347573, 'HP:0006528', 'Chronic lung disease', 'MP:0031483', 'decreased urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347574, 'HP:0006528', 'Chronic lung disease', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347575, 'HP:0006528', 'Chronic lung disease', 'MP:0008673', 'decreased interleukin-13 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347576, 'HP:0006528', 'Chronic lung disease', 'MP:0012553', 'decreased serum complement activity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347577, 'HP:0006528', 'Chronic lung disease', 'MP:0005426', 'tachypnea', 0.45161290322580644, 8.526773851447254, 1.962345814121962, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347578, 'HP:0006528', 'Chronic lung disease', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347579, 'HP:0006528', 'Chronic lung disease', 'MP:0003882', 'abnormal pulse pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347580, 'HP:0006528', 'Chronic lung disease', 'MP:0003633', 'abnormal nervous system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347581, 'HP:0006528', 'Chronic lung disease', 'MP:0003216', 'absence seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347582, 'HP:0006528', 'Chronic lung disease', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347583, 'HP:0006528', 'Chronic lung disease', 'MP:0010636', 'bundle branch block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347584, 'HP:0006528', 'Chronic lung disease', 'MP:0001664', 'abnormal digestion', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347585, 'HP:0006528', 'Chronic lung disease', 'MP:0011918', 'abnormal PQ interval', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347586, 'HP:0006528', 'Chronic lung disease', 'MP:0000751', 'myopathy', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347587, 'HP:0006528', 'Chronic lung disease', 'MP:0002161', 'abnormal fertility/fecundity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347588, 'HP:0006528', 'Chronic lung disease', 'MP:0006383', 'abnormal cochlear frequency tuning', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347589, 'HP:0006528', 'Chronic lung disease', 'MP:0001845', 'abnormal inflammatory response', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347590, 'HP:0006528', 'Chronic lung disease', 'MP:0004781', 'abnormal surfactant composition', 0.56, 8.526773851447254, 2.1851758182833856, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347591, 'HP:0006528', 'Chronic lung disease', 'MP:0014037', 'stranguria', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347592, 'HP:0006528', 'Chronic lung disease', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347593, 'HP:0006528', 'Chronic lung disease', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347594, 'HP:0006528', 'Chronic lung disease', 'MP:0001596', 'hypotension', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347595, 'HP:0006528', 'Chronic lung disease', 'MP:0010992', 'increased surfactant secretion', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347596, 'HP:0006528', 'Chronic lung disease', 'MP:0012685', 'abnormal primitive streak elongation', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347597, 'HP:0006528', 'Chronic lung disease', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347598, 'HP:0006528', 'Chronic lung disease', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347599, 'HP:0006528', 'Chronic lung disease', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347600, 'HP:0006528', 'Chronic lung disease', 'MP:0031095', 'pharyngitis', 0.4666666666666667, 8.526773851447254, 1.9947834796477, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347601, 'HP:0006528', 'Chronic lung disease', 'MP:0010553', 'prolonged HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347602, 'HP:0006528', 'Chronic lung disease', 'MP:0002405', 'respiratory system inflammation', 0.4827586206896552, 8.526773851447254, 2.028884812762246, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347603, 'HP:0006528', 'Chronic lung disease', 'MP:0030938', 'abnormal reticulophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347604, 'HP:0006528', 'Chronic lung disease', 'MP:0005403', 'abnormal nerve conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347605, 'HP:0006528', 'Chronic lung disease', 'MP:0014041', 'increased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347606, 'HP:0006528', 'Chronic lung disease', 'MP:0008069', 'abnormal joint mobility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347607, 'HP:0006528', 'Chronic lung disease', 'MP:0030909', 'abnormal melanocyte adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347608, 'HP:0006528', 'Chronic lung disease', 'MP:0002136', 'abnormal kidney physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347609, 'HP:0006528', 'Chronic lung disease', 'MP:0002292', 'abnormal gestational length', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347610, 'HP:0006528', 'Chronic lung disease', 'MP:0006152', 'tunnel vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347611, 'HP:0006528', 'Chronic lung disease', 'MP:0004558', 'delayed allantois development', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347612, 'HP:0006528', 'Chronic lung disease', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347613, 'HP:0006528', 'Chronic lung disease', 'MP:0008272', 'abnormal endochondral bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347614, 'HP:0006528', 'Chronic lung disease', 'MP:0001379', 'abnormal penile erection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347615, 'HP:0006528', 'Chronic lung disease', 'MP:0021015', 'increased tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347616, 'HP:0006528', 'Chronic lung disease', 'MP:0014043', 'decreased cellular sensitivity to cisplatin', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347617, 'HP:0006528', 'Chronic lung disease', 'MP:0011900', 'podocyturia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347618, 'HP:0006528', 'Chronic lung disease', 'MP:0012124', 'increased bronchoconstrictive response', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347619, 'HP:0006528', 'Chronic lung disease', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347620, 'HP:0006528', 'Chronic lung disease', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347621, 'HP:0006528', 'Chronic lung disease', 'MP:0012046', 'decreased susceptibility to hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347622, 'HP:0006528', 'Chronic lung disease', 'MP:0011221', 'decreased intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347623, 'HP:0006528', 'Chronic lung disease', 'MP:0011952', 'decreased cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347624, 'HP:0006528', 'Chronic lung disease', 'MP:0002322', 'abnormal respiratory transport', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347625, 'HP:0006528', 'Chronic lung disease', 'MP:0010993', 'decreased surfactant secretion', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347626, 'HP:0006528', 'Chronic lung disease', 'MP:0011805', 'decreased cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347627, 'HP:0006528', 'Chronic lung disease', 'MP:0009046', 'muscle twitch', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347628, 'HP:0006528', 'Chronic lung disease', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347629, 'HP:0006528', 'Chronic lung disease', 'MP:0005257', 'abnormal intraocular pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347630, 'HP:0006528', 'Chronic lung disease', 'MP:0003996', 'clonic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347631, 'HP:0006528', 'Chronic lung disease', 'MP:0008688', 'decreased interleukin-2 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347632, 'HP:0006528', 'Chronic lung disease', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347633, 'HP:0006528', 'Chronic lung disease', 'MP:0008004', 'abnormal stomach pH', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347634, 'HP:0006528', 'Chronic lung disease', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347635, 'HP:0006528', 'Chronic lung disease', 'MP:0000740', 'impaired smooth muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347636, 'HP:0006528', 'Chronic lung disease', 'MP:0009661', 'abnormal pregnancy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347637, 'HP:0006528', 'Chronic lung disease', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347638, 'HP:0006528', 'Chronic lung disease', 'MP:0004010', 'increased diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347639, 'HP:0006528', 'Chronic lung disease', 'MP:0020371', 'abnormal glymphatic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347640, 'HP:0006528', 'Chronic lung disease', 'MP:0011717', 'increased interleukin-8 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347641, 'HP:0006528', 'Chronic lung disease', 'MP:0008776', 'increased right ventricle peak pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347642, 'HP:0006528', 'Chronic lung disease', 'MP:0001914', 'hemorrhage', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347643, 'HP:0006528', 'Chronic lung disease', 'MP:0011048', 'decreased lung tissue damping', 0.5833333333333334, 8.526773851447254, 2.230235730442913, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347644, 'HP:0006528', 'Chronic lung disease', 'MP:0008271', 'abnormal bone ossification', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347645, 'HP:0006528', 'Chronic lung disease', 'MP:0003091', 'abnormal cell migration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347646, 'HP:0006528', 'Chronic lung disease', 'MP:0002328', 'abnormal airway resistance', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347647, 'HP:0006528', 'Chronic lung disease', 'MP:0002133', 'abnormal respiratory system physiology', 0.6363636363636364, 8.526773851447254, 2.329405249104875, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347648, 'HP:0006528', 'Chronic lung disease', 'MP:0005087', 'decreased acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347649, 'HP:0006528', 'Chronic lung disease', 'MP:0008651', 'increased interleukin-1 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347650, 'HP:0006528', 'Chronic lung disease', 'MP:0002987', 'abnormal urine osmolality', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347651, 'HP:0006528', 'Chronic lung disease', 'MP:0004879', 'decreased systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347652, 'HP:0006528', 'Chronic lung disease', 'MP:0002909', 'abnormal adrenal gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347653, 'HP:0006528', 'Chronic lung disease', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347654, 'HP:0006528', 'Chronic lung disease', 'MP:0014030', 'abnormal mucous gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347655, 'HP:0006528', 'Chronic lung disease', 'MP:0003096', 'increased corneal light-scattering', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347656, 'HP:0006528', 'Chronic lung disease', 'MP:0009567', 'mitotic nondisjunction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347657, 'HP:0006528', 'Chronic lung disease', 'MP:0001629', 'abnormal heart rate', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347658, 'HP:0006528', 'Chronic lung disease', 'MP:0002907', 'abnormal parturition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347659, 'HP:0006528', 'Chronic lung disease', 'MP:0008861', 'abnormal hair shedding', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347660, 'HP:0006528', 'Chronic lung disease', 'MP:0012034', 'abnormal a-wave shape', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347661, 'HP:0006528', 'Chronic lung disease', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347662, 'HP:0006528', 'Chronic lung disease', 'MP:0004485', 'increased response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347663, 'HP:0006528', 'Chronic lung disease', 'MP:0003463', 'abnormal single cell response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347664, 'HP:0006528', 'Chronic lung disease', 'MP:0020439', 'absent b-wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347665, 'HP:0006528', 'Chronic lung disease', 'MP:0008943', 'increased sensitivity to induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347666, 'HP:0006528', 'Chronic lung disease', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347667, 'HP:0006528', 'Chronic lung disease', 'MP:0004925', 'decreased susceptibility to noise-induced hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347668, 'HP:0006528', 'Chronic lung disease', 'MP:0001598', 'abnormal blood viscosity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347669, 'HP:0006528', 'Chronic lung disease', 'MP:0005044', 'sepsis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347670, 'HP:0006528', 'Chronic lung disease', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347671, 'HP:0006528', 'Chronic lung disease', 'MP:0006049', 'semilunar valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347672, 'HP:0006528', 'Chronic lung disease', 'MP:0001752', 'abnormal hypothalamus secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347673, 'HP:0006528', 'Chronic lung disease', 'MP:0003468', 'increased single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347674, 'HP:0006528', 'Chronic lung disease', 'MP:0008708', 'increased interleukin-7 secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347675, 'HP:0006528', 'Chronic lung disease', 'MP:0014120', 'focal seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347676, 'HP:0006528', 'Chronic lung disease', 'MP:0005501', 'abnormal skin physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347677, 'HP:0006528', 'Chronic lung disease', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347678, 'HP:0006528', 'Chronic lung disease', 'MP:0002335', 'decreased airway responsiveness', 0.5185185185185185, 8.526773851447254, 2.1026864115209554, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347679, 'HP:0006528', 'Chronic lung disease', 'MP:0008566', 'increased interferon-gamma secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347680, 'HP:0006528', 'Chronic lung disease', 'MP:0006003', 'abnormal large intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347681, 'HP:0006528', 'Chronic lung disease', 'MP:0013634', 'increased femur fracture load', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347682, 'HP:0006528', 'Chronic lung disease', 'MP:0005576', 'decreased pulmonary ventilation', 0.5384615384615384, 8.526773851447254, 2.1427411803957814, 'UPHENO:0002448', 'abnormality of respiratory system physiology'),
(347683, 'HP:0006528', 'Chronic lung disease', 'MP:0031066', 'cytokine storm', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(347684, 'HP:0006528', 'Chronic lung disease', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
